Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-04-014497
Filing Date
2004-03-05
Accepted
2004-03-05 11:43:29
Documents
1
Period of Report
2004-03-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7570
  Complete submission text file 0001209191-04-014497.txt   9433
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O OSI PHARMACEUTICALS INC 58 S SERVICE RD MELVILLE NY 11747
Business Address
AMPER LINDA E (Reporting) CIK: 0001220024 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15190 | Film No.: 04650929